Kiromic Biopharma (KRBP)
OTHER OTC:KRBP
US Market
Holding KRBP?
Track your performance easily

Kiromic Biopharma (KRBP) Technical Analysis

19 Followers

Summary of all the Indicators

Overall Consensus
Sell
6Bullish
1Neutral
15Bearish
Technical Analysis Consensus
Buy
6Bullish
1Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Kiromic Biopharma’s (KRBP) Moving Averages Convergence Divergence (MACD) indicator is -0.16, suggesting Kiromic Biopharma is a Buy.
Kiromic Biopharma’s (KRBP) 20-Day exponential moving average is 1.68, while Kiromic Biopharma’s (KRBP) share price is $1.4, making it a Sell.
Kiromic Biopharma’s (KRBP) 50-Day exponential moving average is 1.88, while Kiromic Biopharma’s (KRBP) share price is $1.4, making it a Sell.

Kiromic Biopharma (KRBP) Pivot Points

Sep 28, 2024, 10:17 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.13
1.27
1.33
1.47
1.53
1.67
1.73
Fibonacci
1.27
1.34
1.39
1.47
1.54
1.59
1.67
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Kiromic Biopharma (KRBP) Moving Averages

Sep 28, 2024, 10:17 PM
Period
Simple
Exponential
MA5
1.42Sell
1.44Sell
MA10
1.53Sell
1.54Sell
MA20
1.76Sell
1.68Sell
MA50
1.84Sell
1.88Sell
MA100
2.23Sell
2.01Sell
MA200
2.15Sell
1.78Sell
Kiromic Biopharma’s (KRBP) 10-Day exponential moving average is 1.54, while Kiromic Biopharma’s (KRBP) share price is $1.4, making it a Sell.
Kiromic Biopharma’s (KRBP) 100-Day exponential moving average is 2.01, while Kiromic Biopharma’s (KRBP) share price is $1.4, making it a Sell.
Kiromic Biopharma’s (KRBP) stock price is $1.4 and Kiromic Biopharma’s (KRBP) 50-day simple moving average is 1.84, creating a Sell signal.
Kiromic Biopharma’s (KRBP) stock price is $1.4 and Kiromic Biopharma’s (KRBP) 100-day simple moving average is 2.23, creating a Sell signal.
Kiromic Biopharma’s (KRBP) stock price is $1.4 and Kiromic Biopharma’s (KRBP) 200-day simple moving average is 2.15, creating a Sell signal.

Kiromic Biopharma (KRBP) Technical Indicators

Sep 28, 2024, 10:17 PM
Name
Value
Implied Action
RSI (14)
34.59
Neutral
STOCH (9,6)
5.56
Buy
STOCHRSI (14)
4.76
Buy
MACD (12,26)
-0.16
Buy
ADX (14)
15.82
Buy
Williams %R
-100.00
Buy
CCI (14)
-108.24
Buy
ATR (14)
0.14
-
Ultimate Oscillator
18.99
Sell
ROC
-32.04
Sell
Kiromic Biopharma’s (KRBP) Relative Strength Index (RSI) is 34.59, creating a Neutral signal.
Kiromic Biopharma’s (KRBP) Trend Strength Indicator (ADX) is 15.82, creating a Buy signal.
Kiromic Biopharma’s (KRBP) Commodity Channel Index (CCI) is -108.24, creating a Buy signal.
Kiromic Biopharma’s (KRBP) Price Rate of Change (ROC) is -32.04, creating a Sell signal.

FAQ

Is KRBP a Buy, Hold, or Sell?
Based on KRBP’s technical indicators, KRBP is a Sell.
    What is KRBP’s RSI (14)?
    KRBP’s RSI (14) is 34.59, which suggests KRBP is a Neutral.
      What is KRBP’s MACD?
      KRBP’s MACD is -0.16, which suggests KRBP is a Buy.
        What is KRBP’s 5-day moving average?
        KRBP’s 5-day moving average is 1.42, which suggests KRBP is a Sell.
          What is KRBP’s 20-day moving average?
          KRBP 20-day moving average is 1.76, which suggests KRBP is a Sell.
            What is KRBP’s 50-day moving average?
            KRBP’s 50-day moving average is 1.84, which suggests KRBP is a Sell.
              What is KRBP’s 200-day moving average?
              KRBP’s 200-day moving average is 2.15, which suggests KRBP is a Sell.
                What is KRBP’s Williams % R (14)?
                KRBP’s Williams % R (14) is -100.00, which suggests KRBP is a Buy.
                  What is KRBP’s CCI (14)?
                  KRBP’s CCI (14) is -108.24, which suggests KRBP is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis